Citadel Advisors
KANG

Citadel Advisors’s iKang Healthcare Group, Inc. KANG Stock Holding History

Citadel Advisors’s Portfolio KANG Stock Details KANG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-16,200
Closed -$323K – 9570
2018
Q1 		$323K Buy
16,200
+600
+4% +$10.1K ﹤0.01% 6630
2017
Q4 		$246K Sell
15,600
-10,000
-39% -$144K ﹤0.01% 6777
2017
Q3 		$345K Sell
25,600
-11,700
-31% -$157K ﹤0.01% 5857
2017
Q2 		$458K Sell
37,300
-36,300
-49% -$526K ﹤0.01% 5249
2017
Q1 		$1.07M Sell
73,600
-79,200
-52% -$1.3M ﹤0.01% 3887
2016
Q4 		$2.65M Buy
152,800
+125,200
+454% +$2.12M ﹤0.01% 2632
2016
Q3 		$499K Buy
27,600
+17,100
+163% +$315K ﹤0.01% 4857
2016
Q2 		$193K Buy
+10,500
New +$211K ﹤0.01% 5865

Other funds holding KANG

FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
CI
Conning Inc Hartford, Connecticut $3.01B AUM 16.23% 1-Year Est. Return

Citadel Advisors's KANG Position: Q2 2018 in Review

Citadel Advisors sold out of iKang Healthcare Group, Inc. (KANG) in Q2 2018, closing a stake of 10,944 shares — an estimated $221K sold.

Citadel Advisors first reported a position in KANG in Q3 2014 and held it in 11 quarters. The position peaked at $2.9M in Q4 2016. 63 funds tracked by Wall St. Rank hold KANG as of Q2 2018.

  • Citadel Advisors reported no remaining iKang Healthcare Group, Inc. position as of Q2 2018 after selling out during the quarter.
  • Citadel Advisors sold 10,944 iKang Healthcare Group, Inc. shares in Q2 2018, an estimated $221K.
  • Citadel Advisors first reported a position in iKang Healthcare Group, Inc. in Q3 2014 and held it in 11 quarters.
  • Citadel Advisors's iKang Healthcare Group, Inc. position peaked at $2.9M in Q4 2016.
  • 63 funds tracked by Wall St. Rank held iKang Healthcare Group, Inc. as of Q2 2018.

Based on Citadel Advisors's 13F filing for Q2 2018, filed 10 Aug 2018.